Comparative Genomic Analysis of Three Paenibacillus polymyxa Strains Isolated from Termitarium and Identification of
Boomiga Rathakrishnan1, Venkatesan Dhanalakshmi1, Jeyaprakash Rajendhran2
1Department of Genetics, School of Biological Sciences, Madurai Kamaraj University, Madurai, 625021, India.
Abstract:
The emergence of multidrug-resistant (MDR) pathogens poses a significant global threat in healthcare settings, emphasizing the critical need for novel antibiotic discovery. Consequently, international efforts are continuously directed towards identifying new antibiotics from diverse microbial sources. We investigated the biosynthetic potential of three Paenibacillus polymyxa strains isolated from a termitarium, WGTm-28, WGTm-93, and WGTm-147. These strains exhibited a broad-spectrum of antimicrobial activity against clinical and plant pathogens. Whole-genome sequencing using the Illumina platform and subsequent annotation revealed 112 biosynthetic gene clusters (BGCs) responsible for synthesizing diverse secondary metabolites. Notably, BGCs encoding polymyxin, fusaricidin B, and tridecaptin were identified in all three strains. Anabaenopeptin NZ857/nostamide A was found in WGTm-28 and WGTm-93, while paenibacillin and paenilan were found only in WGTm-93. A BGC coding for rhizomideA/B/C was exclusively present in WGTm-147. BGCs encoding marthiapeptide A, aurantinin B/C/D, cerecidin, paenibacterin, paenicidin B, and calyculin A were identified with lower identity (from 28 to 60%) with previously reported organisms. Interestingly, 33 putative NRPS BGCs, hybrid clusters, and PKSs BGC were discovered with ≤ 25% or no identity to known antibiotics, suggesting the potential of synthesizing novel antimicrobial agents by these strains.
Insights
Multidrug-resistant pathogens necessitate new antibiotics. Paenibacillus polymyxa strains from a termitarium yielded 112 biosynthetic gene clusters, including known and novel antimicrobial compounds, offering potential solutions.
Area of Science:
- Microbiology
- Biotechnology
- Drug Discovery
Background:
- Multidrug-resistant (MDR) pathogens present a critical global health challenge.
- Novel antibiotic discovery is essential to combat the rise of MDR infections.
- Microbial natural products are a vital source for identifying new antimicrobial agents.
Purpose of the Study:
- To explore the biosynthetic potential of three Paenibacillus polymyxa strains isolated from a termitarium.
- To identify secondary metabolites and biosynthetic gene clusters (BGCs) with antimicrobial activity.
- To assess the potential for novel antibiotic discovery from these bacterial isolates.
Main Methods:
- Isolation and cultivation of Paenibacillus polymyxa strains from a termitarium.
- Antimicrobial activity screening against clinical and plant pathogens.
- Whole-genome sequencing using the Illumina platform and bioinformatics annotation of BGCs.
Main Results:
- All three strains (WGTm-28, WGTm-93, WGTm-147) exhibited broad-spectrum antimicrobial activity.
- A total of 112 BGCs were identified, including those for known antibiotics like polymyxin, fusaricidin B, and tridecaptin.
- Novel BGCs with low sequence identity to known antibiotics were discovered, including 33 putative NRPS, hybrid, and PKS clusters.
Conclusions:
- Paenibacillus polymyxa strains from termitaria are a rich source of diverse secondary metabolites.
- These strains possess BGCs for known antibiotics and novel compounds with potential antimicrobial applications.
- Further investigation of these novel BGCs could lead to the development of new antibiotics to combat MDR pathogens.
More Related Videos
Related Concept Videos
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Bacterial Phylum Actinobacteria
Production of Antibiotics


